September 5th, 2013
Rosiglitazone Revisited
Richard G. Bach, MD and John Ryan, MD
Richard G. Bach discusses his study group’s observational analysis of data from the BARI 2D trial regarding outcomes associated with rosiglitazone.
July 16th, 2012
Selections from Richard Lehman’s Literature Review: July 16th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include studies on rhythm vs. rate control in AF, thiazolidinediones and the risk for macular edema, and the effect of acadesine on morbidity and mortality associated with CABG.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?